Nicholas Hall’s CHC.NewDirections is an e-newsletter delivered fortnightly and includes an inspired mix of global consumer healthcare news and commentary from the viewpoint of the self-care industry, backed by insights from industry experts.
LARGE STUDY FINDS OTC NASAL SPRAYS REDUCE URTI DURATION
| UK: Widely available OTC nasal sprays could keep URTIs at bay and prevent full-blown symptoms from developing ...
CYTISINE ACHIEVES BREAKTHROUGH THERAPY DESIGNATION FOR VAPING CESSATION
| USA: The FDA has granted Breakthrough Therapy Designation for Achieve Life Sciences’ cytisine (cytisinicline) for nicotine e-cigarette / vaping cessation ...
BAYER, HURDLE INTRODUCE “INFLAMMAGE” BIOMARKER
| UK / USA / SWITZERLAND: A study conducted by diagnostic testing company Hurdle.bio / Chronomics, Bayer Consumer Health and multiple academic institutions introduces and validates “InflammAge” ...
Trademarked or patented ingredients & molecules, licensing opportunities and brands seeking partners
Important launches, line extensions & adjacencies (registered CHCs and supplements) with innovative formulations, claims or indications – includes stand-out contributions from our sister service, CHC New Products Tracker
Technological and scientific advancements, delivery methods, early-stage developments
Substance-based devices, mechanical devices, diagnostics
Scientific studies, clinical trials
Rx-to-OTC switch, reverse switch, access to medicines
Mobile & Web apps, wearables, internet connected devices, telehealth
Approvals, collaborations, regulatory affairs, guidance
New or additional claims approved for specific ingredients or products, disallowed advertising claims, plus alerts and warnings
Key regulatory developments and product launches as this new category evolves in specific markets
Scientific research, opinion, product development, regulation
Spotlight on a specific topic
1.
2.
3.
CHC.NewDirections covers all major regions providing you with the essential information to keep you informed of the latest developments affecting your business.
The website also provides you with the opportunity to take a deeper look at trends via the news archive, Supplements Focus and Switch List.
Prepared by our expert team:
Kirsten McEwan
Editor
CHC.NewDirections
Nina Stimson
VP & Consulting Editor
CHC.NewDirections
© Nicholas Hall Group of Companies 2018. Privately owned and trademarked under these terms and conditions. Privacy policy